Compare2 funds · 1 pair
Picked · 2YTD
BBCvsXBIVersus · 5Y · 32.8% held in common2–4measures won
Close to theseFee · YTD
Best of the twoNov 5
  • Lowest cost$ a year on $10kXBI 0.35%
  • Most incometrailing 12-month yieldBBC 1.61%
  • Best 5 yearsper yearXBI +3.4%
  • Smallest drop · 1Yworst fall in the past yearXBI −14.9%
Measures won2–4XBI wins · of 6 · 5Y
$10,000 · 5Y$11,836XBI · BBC $9,380
Lowest cost0.35%XBI · $35 on $10k
Most income1.61%BBC · $161 on $10k
Smallest drop−14.9%XBI · worst fall in 1Y
Held in common32.8%BBC and XBI

BBC vs XBI

5Y
BBC
XBI
Virtus Biotech Clinical Trials ETF · $34MState Street SPDR S&P Biotech ETF · $10.6B
+33.0%3 years · per year$23,503 · $22,550+31.1%
−1.3%5 years · per year$9,380 · $11,836+3.4%
0.65%Expense ratio$65 · $35 on $10k · lower wins0.35%
1.61%12-mo yield$161 · $37 on $10k0.37%
−30.2%Worst dropSmaller wins−14.9%
38.2%VolatilityLower wins29.9%
2–4XBI wins
$10,000 · 5 yearsOne scale
$10k startXBI $11.8kBBC $9.4kOct 2021Nov 2026
Shared top holdingsBBC · XBI
2.2%KOD1.2%
1.2%KYMR1.4%
1.1%ORKA1.6%
1.1%PCVX1.3%
Held in common32.8%
End-of-day Nov 5, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1BXBIState Street SPDR S&P Biotech ETFReadDesk0.35%0.37%−6.7%+21.8%+37.9%+31.1%+3.4%−14.9%$10.6B
2ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.61%−6.6%+5.6%+36.3%+33.0%−1.3%−30.2%$34M
End-of-day Nov 5, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs XBI

5Y
Virtus Biotech Clinical Trials
$9,381
SPDR S&P Biotech
$11,836
$5k$10kNov 2021Nov 2026$9,381$11,836$5k$10kNov 2021Nov 2026$9,381$11,836
MeasureBBCXBI
Fee0.65%0.35%
Cost on $10k a year$65$35
Yield1.61%0.37%
5 years, per year−1.3%+3.4%
3 years, per year+33.0%+31.1%
Worst drop · 1Y−30.2%−14.9%
Volatility · 1Y38.2%29.9%
4–2measures won
XBI first
32.8%
holdings shared
Nov 5, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+32.3%
VIGVanguard
+12.5%
Jan 1Nov 5+32.3%+12.5%
+32.3%Year to date+12.5%
3.0%Yield1.5%
$123BAssets$109B
2–0SCHD wins
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+8.5%
JEPIJ.P. Morgan
+5.2%
Jan 1Nov 5+8.5%+5.2%
+8.5%Year to date+5.2%
12.2%Yield8.1%
$42.1BAssets$46.1B
2–0JEPQ wins
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+8.4%
SPYSPDR
+8.3%
Jan 1Nov 5+8.4%+8.3%
+8.4%Year to date+8.3%
1.1%Yield1.0%
$182BAssets$805B
2–0SPYM wins
End-of-day Nov 5, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, XBI

Today
32.8%most shared, BBC and XBI
BBCXBI
BBC—32.8%
XBI32.8%—
End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$96most kept, BBC
BBC$161 − $65 = $96
XBI$37 − $35 = $2
KeptFee
End-of-day Nov 5, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com